Cargando…
Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study()
BACKGROUND: Genomic analysis of circulating tumor DNA (ctDNA) is increasingly incorporated into the clinical management of patients with advanced cancer. Beyond tumor profiling, ctDNA analysis also can enable calculation of circulating tumor fraction (TF), which has previously been found to be progn...
Autores principales: | Reichert, Z. R., Morgan, T. M., Li, G., Castellanos, E., Snow, T., Dall’Olio, F. G., Madison, R. W., Fine, A. D., Oxnard, G. R., Graf, R. P., Stover, D. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805517/ https://www.ncbi.nlm.nih.gov/pubmed/36208697 http://dx.doi.org/10.1016/j.annonc.2022.09.163 |
Ejemplares similares
-
Principles of medical and oncological management of giant masses of the mediastinum: a narrative review
por: Conci, Nicole, et al.
Publicado: (2022) -
Epigenetic Bases of Aberrant Glycosylation in Cancer
por: Dall’Olio, Fabio, et al.
Publicado: (2017) -
Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples
por: Husain, Hatim, et al.
Publicado: (2022) -
Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers
por: Trinchera, Marco, et al.
Publicado: (2017) -
The Cancer-Associated Antigens Sialyl Lewis(a/x) and Sd(a): Two Opposite Faces of Terminal Glycosylation
por: Dall’Olio, Fabio, et al.
Publicado: (2021)